Searched for
ZYDUS LIFE USFDA
Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in IndiaZydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and a...- Zydus Lifesciences shares in focus after USFDA nod for Verapamil Hydrochloride ER TabletsZydus Lifesciences will be in focus on Wednesday after receiving final USFDA approval for its Verapamil Hydrochloride Extended-Release Tabl...
- Zydus Lifesciences shares in focus after Ahmedabad oncology unit gets USFDA EIRZydus Lifesciences got a USFDA clearance upgrade for its Ahmedabad oncology plant, moving from OAI to VAI status after a June inspection—a ...
- Stocks in news: HDFC Life, HDB Financial, Tech Mahindra, Dixon Tech, ITC HotelsThe markets saw a slight recovery on Tuesday after a four-day losing streak. Several companies are in focus due to recent news and quarterl...
- Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drugZydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for...
- Zydus Life shares rise 2% after USFDA nod for Eluxadoline tabletsZydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) fo...
- Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...
- Stocks in news: Wipro, IRFC, TCS, Zydus Life, LIC HousingLIC Housing Finance said its board has given a nod to borrow Rs 1.23 lakh crore through loans, issue of bonds, and other instruments, in th...
- Stocks in news: Wipro, Kotak Bank, Zomato, Motilal Oswal, Adani EnergyIT services company Wipro reported 24% growth in its consolidated net profit at Rs 3,354 crore, while revenue from operations rose by a mar...
- Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...
- Stocks in news: JSW Energy, IDFC First Bank, Zydus Life, Alkem Labs, Tata ElxsiJSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the compan...
- Stocks in news: Nazara Tech, ZEE, Anupam Rasayan, Tata Chemicals, Kotak BankShares of Tata Chemicals and Canara Bank will be in focus today as the companies will go ex-dividend today. Tata Chemicals has also followe...
- Stocks in news: SBI Life, Indian Overseas Bank, IOC, IDFC First BankUSFDA has conducted an inspection at Zydus’ animal health drug manufacturing facility at SEZ, Ahmedabad. The inspection concluded with nil ...
- Zydus Life receives final USFDA approval for insomnia drugThe approval granted by the US Food and Drug Administration (USFDA) is to market Triazolam tablets of strengths 0.125 mg and 0.25 mg, the c...
- Zydus' US subsidiary acquires speciality drug asset in USUnder the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...
- Zydus Cadila receives orphan drug status from USFDA for its novel malaria drugDrug maker Cadila Healthcare (Zydus Cadila), on Thursday said its antimalarial drug ZY19489 (MMV253), currently in development together wit...
- European Medicines Agency grants Orphan Drug Designation to Zydus Cadila's Saroglitazar MgOrphan Drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare, life-threatening, or ch...
- USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar MgZydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, includ...
- Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vialZydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Li...
- Natco will out-license molecules to big pharma: Amit Rajan, Director, Celogen LifeAmit Rajan, Director, Celogen Life says that Micro Labs will quickly come out of the FDA and midcap space as they have a good R&D pipeline.
Load More
